- 全部删除
 
您的购物车当前为空
B-Raf IN 17 (Compound 8e) 是一种高效且可口服的II型多激酶抑制剂。在A375细胞系中,其对BRAFWT、VEGFR-2和FGFR-1展现出良好的细胞水平抑制效果,IC50值分别为0.02、0.18和1.65μM。B-Raf IN 17 可用于癌症研究。
B-Raf IN 17 (Compound 8e) 是一种高效且可口服的II型多激酶抑制剂。在A375细胞系中,其对BRAFWT、VEGFR-2和FGFR-1展现出良好的细胞水平抑制效果,IC50值分别为0.02、0.18和1.65μM。B-Raf IN 17 可用于癌症研究。

B-Raf IN 17 相关产品
| 产品描述 | B-Raf IN 17 (Compound 8e) is an effective, orally active type II multi-kinase inhibitor. It shows potent cellular inhibition against BRAFWT, VEGFR-2, and FGFR-1 in the A375 cell line, with IC50 values of 0.02, 0.18, and 1.65 μM, respectively. B-Raf IN 17 is applicable for cancer research.  | 
| 体内活性 | B-Raf IN 17 (10-20mg/kg,口服,每周 3 次,持续 21 天) 能抑制 C57BL/6 小鼠中 B16F10 细胞所致的肿瘤生长。  | 
| 分子式 | C22H14BrN5O2 | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
评论内容